Invention Grant
- Patent Title: Anti-OX40 antibodies and their uses
-
Application No.: US15908221Application Date: 2018-02-28
-
Publication No.: US10040864B2Publication Date: 2018-08-07
- Inventor: Fiona A. Harding
- Applicant: AbbVie Biotherapeutics Inc.
- Applicant Address: US CA Redwood City
- Assignee: AbbVie Biotherapeutics Inc.
- Current Assignee: AbbVie Biotherapeutics Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Dechert LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C07K16/30 ; C12N15/85 ; A61P35/00
Abstract:
The present disclosure provides novel anti-OX40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.
Public/Granted literature
- US20180194855A1 ANTI-OX40 ANTIBODIES AND THEIR USES Public/Granted day:2018-07-12
Information query
